Quality of Working Life Can Protect Against Cognitive and Emotional Vulnerability in Women Living with Metastatic Breast Cancer: a Cross-sectional Study

Overview

Journal J Cancer Surviv

Specialty Oncology

Date 2022 Jan 17

PMID 35038120

Authors

Bethany Chapman

Elizabeth A Grunfeld

Nazanin Derakshan

Affiliations

Soon will be listed here.

Abstract

Purpose: Research focusing on the cognitive and emotional health of women with metastatic breast cancer (MBC) is limited. The focal aim of the current study was to explore how quality of working life was related to global health, perceived cognitive function, anxiety and depression. To this end, women's experience of employers after MBC diagnosis and its relationship to quality of working life was also explored.

Methods: Women living with MBC (N = 88) completed online questionnaires assessing their global health status, perceived cognitive and emotional vulnerability and their experience of employers following diagnosis. Women working at the time of the study also reported on their quality of working life.

Results: Women's experience of employers after MBC diagnosis was positively related to their quality of working life. Importantly, greater quality of working life met with better perceived cognitive function and global health, as well as lower levels of depression in working women.

Conclusions: Our study is the first to establish the role of quality of working life in protecting against levels of cognitive vulnerability and emotional vulnerability to depression in women with MBC. We also highlight the importance of having a positive experience with employers. Our findings suggest that educational programmes can be provided to employers to enhance their understanding and awareness of the needs of women with MBC.

Implications For Cancer Survivors: Women with MBC may benefit from employers accessing educational (or support) programmes that can increase their awareness of the treatment-related sequelae and needs of women with MBC in the workplace.

Citing Articles

Quality of life of patients treated for stage IV breast cancer. Multidimensional assessment and examination of determining factors.

Arraras J, Illarramendi J, Manterola A, Zarandona U, Ibanez B, Bottomley A Contemp Oncol (Pozn). 2025; 28(4):350-357.

PMID: 39935753 PMC: 11809568. DOI: 10.5114/wo.2024.147006.

Characterizing cancer-related cognitive impairments and impact on quality of life in women with metastatic breast cancer.

Henneghan A, Van Dyk K, Haywood D, Patel M, Franco-Rocha O, Bang S Breast Cancer Res Treat. 2024; 209(1):125-138.

PMID: 39269553 DOI: 10.1007/s10549-024-07479-4.

Factors associated with distress among female cancer survivors at the workplace: A cross-sectional study.

Jin J, Lee E, Lee S J Occup Health. 2022; 64(1):e12364.

PMID: 36261233 PMC: 9581752. DOI: 10.1002/1348-9585.12364.

References

Largillier R, Ferrero J, Doyen J, Barriere J, Namer M, Mari V . Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol. 2008; 19(12):2012-9. PMC: 2733115. DOI: 10.1093/annonc/mdn424. View

Caplette-Gingras A, Savard J . Depression in women with metastatic breast cancer: a review of the literature. Palliat Support Care. 2008; 6(4):377-87. DOI: 10.1017/S1478951508000606. View

Grabsch B, Clarke D, Love A, McKenzie D, Snyder R, Bloch S . Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey. Palliat Support Care. 2006; 4(1):47-56. DOI: 10.1017/s1478951506060068. View

Park E, Gelber S, Rosenberg S, Seah D, Schapira L, Come S . Anxiety and Depression in Young Women With Metastatic Breast Cancer: A Cross-Sectional Study. Psychosomatics. 2018; 59(3):251-258. PMC: 5935568. DOI: 10.1016/j.psym.2018.01.007. View

Carreira H, Williams R, Dempsey H, Stanway S, Smeeth L, Bhaskaran K . Quality of life and mental health in breast cancer survivors compared with non-cancer controls: a study of patient-reported outcomes in the United Kingdom. J Cancer Surviv. 2020; 15(4):564-575. PMC: 8272697. DOI: 10.1007/s11764-020-00950-3. View

Palesh O, Collie K, Batiuchok D, Tilston J, Koopman C, Perlis M . A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol. 2006; 75(1):37-44. PMC: 1894689. DOI: 10.1016/j.biopsycho.2006.11.002. View

Mosher C, Champion V, Hanna N, Jalal S, Fakiris A, Birdas T . Support service use and interest in support services among distressed family caregivers of lung cancer patients. Psychooncology. 2012; 22(7):1549-56. PMC: 3535684. DOI: 10.1002/pon.3168. View

Low C, Stanton A . Activity disruption and depressive symptoms in women living with metastatic breast cancer. Health Psychol. 2014; 34(1):89-92. PMC: 4859754. DOI: 10.1037/hea0000052. View

Giese-Davis J, Collie K, Rancourt K, Neri E, Kraemer H, Spiegel D . Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol. 2010; 29(4):413-20. PMC: 3058287. DOI: 10.1200/JCO.2010.28.4455. View

10.

Meneses K, Azuero A, Hassey L, McNees P, Pisu M . Does economic burden influence quality of life in breast cancer survivors?. Gynecol Oncol. 2011; 124(3):437-43. PMC: 3278545. DOI: 10.1016/j.ygyno.2011.11.038. View

11.

Keim-Malpass J, Levine B, Danhauer S, Avis N . Work-related perceptions and quality of life among breast cancer survivors. Psychooncology. 2015; 25(7):873-6. PMC: 4769689. DOI: 10.1002/pon.3951. View

12.

Tevaarwerk A, Lee J, Terhaar A, Sesto M, Smith M, Cleeland C . Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study. Cancer. 2015; 122(3):438-46. PMC: 4724218. DOI: 10.1002/cncr.29656. View

13.

Cleeland C, Mayer M, Dreyer N, Yim Y, Yu E, Su Z . Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study. Breast. 2014; 23(6):763-9. DOI: 10.1016/j.breast.2014.08.004. View

14.

Lyons K, Newman R, Sullivan M, Pergolotti M, Braveman B, Cheville A . Employment Concerns and Associated Impairments of Women Living With Advanced Breast Cancer. Arch Rehabil Res Clin Transl. 2021; 1(1-2):100004. PMC: 7853337. DOI: 10.1016/j.arrct.2019.100004. View

15.

Munir F, Burrows J, Yarker J, Kalawsky K, Bains M . Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study. J Clin Nurs. 2010; 19(9-10):1362-70. DOI: 10.1111/j.1365-2702.2009.03006.x. View

16.

Mehnert A, de Boer A, Feuerstein M . Employment challenges for cancer survivors. Cancer. 2013; 119 Suppl 11:2151-9. DOI: 10.1002/cncr.28067. View

17.

Chapman B, Derakshan N, Grunfeld E . Exploring primary breast cancer survivors' self-management of sustained cancer-related cognitive impairment in the workplace. Psychooncology. 2021; 31(4):606-613. DOI: 10.1002/pon.5844. View

18.

Brabers A, de Jong J, Groenewegen P, van Dijk L . Social support plays a role in the attitude that people have towards taking an active role in medical decision-making. BMC Health Serv Res. 2016; 16(1):502. PMC: 5031318. DOI: 10.1186/s12913-016-1767-x. View

19.

Love A, Grabsch B, Clarke D, Bloch S, Kissane D . Screening for depression in women with metastatic breast cancer: a comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. Aust N Z J Psychiatry. 2004; 38(7):526-31. DOI: 10.1080/j.1440-1614.2004.01385.x. View

20.

Cheung Y, Lim S, Shwe M, Tan Y, Chan A . Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer. Value Health. 2013; 16(6):1001-13. DOI: 10.1016/j.jval.2013.06.017. View